Research
Research
July 22, 2026 • 5 Min
Tackling KRAS G12D
Dr. Leon Pappas explains the workings of the new KRAS G12D inhibitor, now in phase I/II clinical trials around the US and Australia.
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Research
June 4, 2026 • 4 Min
Final Results of the Daraxonrasib Trial Are Unprecedented
When Dr. Brian Wolpin read the final results from the phase III daraxonrasib trial, everyone was on their feet at the 2026 ASCO meeting.
Research
May 18, 2026 • 3 Min
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you.
Survivor Stories
Survivor Stories
November 2, 2022 • 3 Min
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Survivor Stories
June 27, 2022 • 4 Min
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Survivor Stories
June 1, 2022 • 5 Min
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.
